Jerusalem Pharmaceuticals Market Cap

Jerusalem Pharmaceuticals has a market cap or net worth of 59.2 million as of February 13, 2026. Its market cap has increased by 40.59% in one year.

Market Cap

59.20M

Enterprise Value

53.42M

Revenue

33.42M

Ranking

n/a

PE Ratio

8.49

Stock Price

4.64

Market Cap Chart

Since December 15, 2008, Jerusalem Pharmaceuticals's market cap has increased from 14.89M to 59.20M, an increase of 297.60%. That is a compound annual growth rate of 8.37%.

Market Cap History

Date	Market Cap	% Change
Feb 11, 2026	59.20M	0.84%
Dec 31, 2025	58.71M	19.94%
Dec 24, 2024	48.95M	0.78%
Dec 31, 2023	48.57M	15.89%
Dec 29, 2022	41.91M	16.10%
Dec 23, 2021	36.10M	2.12%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
The National Bank	113.05M
Birzeit Pharmaceuticals Company	109.86M
Quds Bank	100.01M
Palestine Islamic Bank	92.37M
Arab Islamic Bank P.L.C.	79.52M
The Vegetable Oil Industries	78.40M
Palestine Industrial Investment Company	71.25M
Palestine Investment Bank P.L.C.	61.25M

Market Cap Rankings